The Skin and Diabetes Mellitus
1984; Wiley; Volume: 23; Issue: 9 Linguagem: Inglês
10.1111/j.1365-4362.1984.tb05694.x
ISSN1365-4632
AutoresR. Gary Sibbald, Ricky K. Schacter,
Tópico(s)Autoimmune Bullous Skin Diseases
ResumoInternational Journal of DermatologyVolume 23, Issue 9 p. 567-584 The Skin and Diabetes Mellitus Ronald Gary Sibbald M. D., Corresponding Author Ronald Gary Sibbald M. D. faculty of Medicine The University of Toronto, Toronto, Ontario, CanadaAddress for reprints: R. Gary Sibbald, M.D., Department of Dermatology, Toronto General Hospital, 101 College Street, Toronto, Ontarlo M5C 1 L7, Canada.Search for more papers by this authorRicky Kanee Schacter M. D., Ricky Kanee Schacter M. D. faculty of Medicine The University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this author Ronald Gary Sibbald M. D., Corresponding Author Ronald Gary Sibbald M. D. faculty of Medicine The University of Toronto, Toronto, Ontario, CanadaAddress for reprints: R. Gary Sibbald, M.D., Department of Dermatology, Toronto General Hospital, 101 College Street, Toronto, Ontarlo M5C 1 L7, Canada.Search for more papers by this authorRicky Kanee Schacter M. D., Ricky Kanee Schacter M. D. faculty of Medicine The University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this author First published: October 1984 https://doi.org/10.1111/j.1365-4362.1984.tb05694.xCitations: 37AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Oppenheim M: Eigentumliche disseminierte degeneration des Bindegewebes der Haut bei einemim Diabetiker. Z Haut Geschlechtskr 32: 179, 192930. 2 Urbach E: Beitrage zu einer Physiologischen und Pathologischen Chemie der Haut; eine neue Diabetische Stoffwechseldermatose: Nekrobiosis Lipoidica Diabeticorum. Arch Dermatol Syphilol 166: 273, 1932. 3 Muller SA, Winkelmann RK: Necrobiosis lipoidica diabeticorum: A clinical and pathological investigation of 171 cases. Arch Dermatol 93: 272, 1966. 4 Grots IA, Strauss JS, Mescon H: Necrobiosis lipoidica diabeticorum of the abdomen. Arch Dermatol 83: 505, 1961. 5 Gaethe G: Necrobiosis lipoidica diabeticorum of the scalp. Arch Dermatol 89: 865, 1964. 6 Wilson-Jones E: Necrobiosis lipoidica presenting on the face and scalp. Trans St. John's Hosp Dermatol Soc. 57: 202, 1971. 7 Warin RP: Proceedings: Necrobiosis lipoidica diabeticorum disseminata. Br J Dermatol 90: 106, 1974. 8 Mackey JP: Necrobiosis lipoidica diabeticorum involving the scalp and face. Br J Dermatol 93: 729, 1975. 9 Muller SA, Winkelmann RK: Atypical forms of necrosis lipoidica diabeticorum: A report of three cases. Arch Pathol 81: 352, 1966. 10 Muller SA, Winkelmann RK: Necrobiosis lipoidica diabeticorum: Results of glucose-tolerance tests in nondiabetic patients. JAMA 195: 433, 1966. 11 Parra CA: Transepithelial elimination in necrobiosis lipoidica. Br J Dermatol 96: 83, 1977. 12 Miescher G, Leder M: Granulomatosis disciformis chronica et progressiva. Dermatologica 97: 62, 1973. 13 Mehregan AH, Altman J: Miescher's granuloma of the face: A variant of necrobiosis lipoidica-granuloma annulare spectrum. Arch Dermatol 107: 62, 1973. 14 Goldstein S, Moerman EJ, Soeldner JS, et al: Diabetes mellitus and genetic prediabetes: Decreased replicative capacity of culture skin fibroblasts. J Clin Invest 63: 358, 1979. 15 Howard BV, Fields RM, Mott DM, et al: Diabetes and cell growth: Lack of differences in growth characteristics of fibroblasts from diabetic and non-diabetic Pima Indians. Diabetes 29: 119, 1980. 16 Kohn RR, Hamlin CR: Genetic effects on aging of collagen with special reference to diabetes mellitus. Birth Defects 14: 387, 1978. 17 Hildebrand AG, Montgomery H, Rynearson EH: Necrobiosis lipoidica diabeticorum. Arch Intern Med 66: 851, 1940. 18 Knoth W, Fuller H: Zur patho-und histogenese der nekrobiosis lipoidica “diabeticorum.” Arch Dermatol Syphilol 199: 109, 1955. 19 Bauer MF, Hirsch P, Bullick WK, et al: Necrobiosis lipoidica diabeticorum: A cutaneous manifestation of diabetic microangiopathy. Arch Dermatol 90: 558, 1964. 20 Friederici HHR, Tucker WR, Schwartz TB: Observations on small blood vessels of skin in the normal and in diabetic patients. Diabetes 15: 233, 1966. 21 Ryan TJ: Microvascular injury: vasculitis, stasis and ischemia. In: Major Problems in Dermatology. Vol. 7. London , Saunders, 1976. 22 Kilo C, Volger N, Williamson JR: Muscle capillary basement membrane changes related to aging and to diabetes mellitus. Diabetes 21: 881, 1972. 23 Gange RW, Black MM, Carrington P: Defecive neutrophil migration in granuloma annulare, necrobiosis lipoidica and sarcoidosis. Arch Dermatol 115: 32, 1979. 24 Ullman S, Dahl MV: Necrobiosis lipoidica: An immunofluorescent study. Arch Dermatol 113: 1671, 1979. 25 Gabby KH, Hasty K, Breslow JL et al: Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 44: 859, 1977. 26 Sparrow G, Abell E: Granuloma annulare and necrobiosis lipoidica treated jet injector. Br J Dermatol 93: 85, 1975. 27 Eldor A, Diaz EG, Naparstek E: Treatment of diabetic necrobiosis with aspirin and dipyridamole (letter) N Engl J Med 298: 1033, 1978. 28 Hanke CW, Bergfeld WF: Treatment with benzoyl peroxide of ulcer on legs within lesions of necrobiosis lipoidica diabeticorum. J Dermatol Surg Oncol 4: 701, 1978. 29 Rhodes EL: Fibrinolytic agents in the treatment of necrobiosis lipoidica. Br J Dermatol 95: 673, 1976. 30 Marr TJ, Traisman HS, Griffith BH, et al: Necrobiosis lipoidica diabeticorum in a juvenile diabetic: Treatment by excision and skin grafting. Cutis 19: 348, 1977. 31 Wells RS, Smith MA: The natural history of granuloma annulare. Br J Dermatol 75: 199, 1963. 32 Haim S, Friedman-Birnbaum R, Shafrir A: Generalized granuloma annulare: Relationship to diabetes mellitus as revealed in 8 cases. Br J Dermatol 83: 302, 1971. 33 Haim S, Friedman-Birnbaum R, Haim N, et al: Carbohydrate tolerance in patients with granuloma annulare: Study of fiftytwo cases. Br J Dermatol 88: 447, 1973. 34 Eng AM: Erythematous generalized granuloma annulare. Arch Dermatol 115: 1210, 1979. 35 Stankler L, Leslie G: Generalized granuloma annulare: A report of a case and review of the literature. Arch Dermatol 95: 509, 1967. 36 Dicken CH, Carrington SG, Winkelmann RK: Generalized granuloma annulare. Arch Dermatol 99: 556, 1969. 37 Williamson DM, Dykes JRW: Carbohydrate metabolism in granuloma annulare. J Invest Dermatol 58: 400, 1972. 38 Lever WF, Schaumburg-Lever G: Histopathology of the Skin. 5th ed. Philadelphia , JB Lippincott, 1975, p 217. 39 Umbert P, Belcher RW, Winkelmann RK: Lymphokines (MIF) patients with sarcoidosis and cutaneous granuloma. Br J Dermatol 95: 481, 1976. 40 Umbert P, Winkelmann RK: Granuloma annulare: Direct immunofluorescence study. Br J Dermatol 95: 487, 1976. 41 Umbert P, Winkelmann RK: Histologic, ultrastructural and his tochemical studies of granuloma annulare. Arch Dermatol 113: 1681, 1977. 42 Dvorak HF, Mihm MC, Dvorak AM: Morphology of delayed-type hypersensitivity reactions in man. J Invest Dermatol 67: 391, 1976. 43 Dahl MV, Ullman S, Goltz RW: Vasculitis in granuloma annulare: Histopathology and direct immunofluorescence. Arch Dermatol 113: 463, 1977. 44 Dahl MV, Cherney KJ, Lindroos WE: Elevated heparinprecipitable fraction of plasma in granuloma annulare. Arch Dermatol 115: 1059, 1979. 45 Cherney KJ, Lindroos WE, Goltz RW, et al: Leukocyte function in granuloma annulare. Br J Dermatol 101: 23, 1979. 46 Anderson BL, Verdich J: Granuloma annulare and diabetes mellitus. Clin Exp Dermatol 4: 31, 1979. 47 Frieman-Birnbaum R, Haim S, Gideone O, et al: Histocompatability antigens in granuloma annulare: Comparative study of the generalized and localized types. Br J Dermatol 98: 425, 1978. 48 Mobacken H, Lindholm A, Sandberg L: HLA antigens in localized granuloma annulare. Acta Derm Venereal 59: 76, 1979. 49 Giessel M, Graves K, Kalivas J: Treatment of disseminated granuloma annulare with potassium iodide. Arch Dermatol 115: 639, 1979. 50 Kossard S, Winkelman RK: Response of generalized granuloma annulare to alkylating agents. Arch Dermatol 114: 216, 1978. 51 Rudolph RI: Disseminated granuloma annulare treated with low dose chlorambucil, Arch Dermatol 115: 1212, 1979. 52 Melin H: An atrophic circumscribed skin lesion in the lower extremities of diabetics. Acta Med Scand 176:Suppl 423: 1, 1964. 53 Bindley GW: Dermopathy in the diabetic syndrome. Arch Dermatol 92: 625, 1965. 54 Danowski TS, Sabeh G, Sarver ME, et al: Shin spots and diabetes mellitus. Am J Med Sci 251: 570, 1966. 55 Bauer M, Levan NE: Diabetic dermangiopathy: A spectrum including pigmented pretibial patches and necrobiosis lipoidica diabeticorum. Br J Dermatol 83: 528, 1970. 56 Lever WF, Schaumburg-Lever G: Histopathology of the Skin. 5th ed. Philadelphia , JB Lippincott, 1975, p 258. 57 Fisher ER, Danowski TS: Histological, histochemical, and electron microscopic features of the skin spots of diabetes mellitus. Am J Clin Pathol 50: 547, 1968. 58 Lithner F: Cutaneous reaction of the extremities of diabetics to local thermal trauma. Acta Med Scand 198: 319, 1975. 59 Ditzel J: Functional microangiopathy in diabetes mellitus. Diabetes 17: 388, 1968. 60 Goodson WY, Hunt TK: Wound healing and the diabetic patient. Surg Gynecol. Obstet 149: 600, 1979. 61 Savin JA: Bacterial infections in diabetes mellitus. Br J Dermatol 91: 481, 1974. 62 Ficara AJ, Levin MP, Grower MF, et al: A comparison of the glucose and protein content of gingival fluid from diabetics and non-diabetics. J Periodont Res 10: 171, 1975. 63 Domerville DA, Lancaster-Smith M: The aerobic cutaneous microflora of diabetic subjects. Br J Dermatol 89: 395, 1973. 64 Smith JA, O'Connor JJ, Willis AT: Nasal carriage of staphylococus aureus in diabetes mellitus. Lancet ii: 776, 1966. 65 Tuazon CU, Perez A, Kshaba T, et al: Staphylococcus aureus among insulin injecting diabetic patients. JAMA 231: 1272, 1975. 66 Farman AG: Atrophic lesions of the tongue: A prevalence study among 1975 diabetic patients, J Oral Pathol 5: 255, 1976. 67 Ragab AH, Hazlett B, Cowan DH: Response of peripheral blood lymphocytes from patients with diabetes mellitus to phytohemaglutinin and candida albicans antigen. Diabetes 21: 906, 1972. 68 Knight L, Fletcher J: Growth of candida albicans in saliva: Stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 123: 371, 1971. 69 Montes LF, Dobson H, Dodge BG, et al: Erythrasma and diabetes mellitus. Arch Dermatol 99: 674, 1979. 70 Jolly HW, Carpenter CL: Oral glucose tolerance studies in recurent trichophyton rubrum infections. Arch Dermatol 100: 26, 1969. 71 Paley RG, Tunbridge RE: Dermal reactions to insulin therapy. Diabetes 1: 22, 1952. 72 Lynfield Y, Rosman P: Insulin allergy: Report of a case with delayed local reaction. Arch Dermatol 115: 591, 1979. 73 Shore RN, Shelley WB, Kyle GC: Chronic urticaria from isophane insulin therapy: Sensitivity associated with noninsulin components in commercial preparations. Arch Dermatol 111: 94, 1975. 74 Galloway JA, Bressler MR: Insulin treatment in diabetes. Med Clin North Am 62: 633, 1978. 75 Minars N, Fu YS, Escober MR: Biphasic local reaction to a new insulin (U-100). J Allergy Clin Immunol 56: 411. 1975. 76 Wentworth SM, Galloway JA, Davidson JA, et al: An update of results of the use of “single peak” and “single component” insulin in patients with complications of insulin therapy (abstract) Diabetes 25 (Suppl 1): 326, 1976. 77 Feinglos MN, Jegasothy BV: Insulin allergy due to zinc. Lancet i: 122, 1979. 78 Ferland F, Erlich RM: Single-peak insulin in the treatment of insulin-induced fat atrophy. J Pediatr 86: 741, 1975. 79 Palestine RF, Millins JL, Spigel GT, et al: Skin manifestations of pentazocine abuse. J Am Acad Dermatol 2: 47, 1980. 80 Erickson L, Lipschutz DE, Wrigley W, et al: A peculiar cutaneous reaction to repeated injections of insulin. JAMA 290: 934, 1969. 81 Almeypa J, Baker H: Adverse cutaneous reactions to hypoglycemic agents. Br J Dermatol 82: 634, 1970. 82 Stewart RC, Piazza EU, Hyman H, et al: Chlorpropamide therapy of diabetes: An appraisal. N Engl J Med 261: 427, 1959. 83 Rothfield EL, Goldman J, Goldberg HH, et al: Severe chlorpropamide toxicity. JAMA 172: 54, 1960. 84 Yaffee HS: Stevens-Johnson syndrome caused by chlorpropamide. Arch Dermatol 82: 6363, 1960. 85 Bruinsma W: A Guide to Drug Reactions. Amsterdam , Excerpta Medica, 1973, p 99. 86 Hitselberger JF, Fosnaugh RP: Photosensitivity due to chlorpropamide. JAMA 180: 62. 1962. 87 Hurlbut WB: Lichen planus (?) tolbutamide drug eruption. Arch Dermatol 88: 105, 1963. 88 Fitzerald MG, Gaddie R, Malins JM, et al: Alcohol sensitivity in diabetics receiving chlorpropamide. Diabetes 11: 40, 1962. 89 Brown J, Winkelman RK: Acanthosis nigricans: Study of 90 cases. Medicine 47: 33, 1968. 90 Banuchi SR, Cohen L, Lorincz AL, et al: Acanthosis nigricans following diethylstilbestrol therapy. Arch Dermatol 109: 545, 1974. 91 Tromovitch T, Kern S: Acanthosis nigricans-like lesions from nicotinic acid. Arch Dermatol 89: 222, 1964. 92 Curth HO, Aschner BM: Genetic studies on acanthosis nigricans. AMA Arch Dermatol 79: 55, 1959. 93 Kahn CR, Flier JS, Bar RS, et al: The syndromes of insulin resistance and acanthosis nigricans: Insulin-receptor disorders in man. N Engl J Med 294: 739, 1976. 94 Kahn CR, Podskalny JM: Demonstration of a primary (?genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans Type A. J Clin Endocrinol Metab 50: 1139, 1980. 95 Bar RS, Muggeo M, Kahn CR: Characterization of insulin receptors in patients with syndromes of insulin resistance and acanthosis nigricans. Diabetologia 18: 209, 1980. 96 Robinson TJ, Archer JA, Gambhir KK, et al: Erythrocytes: A new cell type for the evaluation of insulin receptor defects in diabetic humans. Science 205: 200, 1979. 97 Flier JS, Young JB, Landsberg L: Familial insulin resistance with acanthosis nigricans, acral hypertrophy and muscle cramps. N Engl J Med 303: 970, 1980. 98 Brubaker MM, Levan NE, Collipp PJ: Acanthosis nigricans and congenital total lipodystrophy. Arch Dermatol 91: 320, 1965. 99 Reed WB, Dexter R, Corley C, et al: Congenital lipodystrophic diabetes with acanthosis nigricans (the Seip-Lawrence syndrome) Arch Dermatol 91: 326, 1965. 100 Wright LA, Tompkins GR, Davidson PC: Acanthosis nigricans and lipoatrophic diabetes. Curtis 3: 713, 1967. 101 Reed WB, Ragsdale W Jr, Curtis AC, et al: Acanthosis nigricans in association with various genodermatoses. Acta Derm Venereol 48: 465, 1968. 102 Muller SA: Dermatologic disorders associated with diabetes mellitus. Mayo Clinic Proc 41: 689, 1966. 103 Baes H, Van Gent CM, Pries C: Lipid composition of various types of xanthoma. J Invest Dermatol 51: 286, 1968. 104 Borrie P, Slack J: A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinemia. Br J Dermatol 90: 245, 1974. 105 Stawski MA, Voorkees JJ: Cutaneous signs of diabetes mellitus. Cutis 18: 415, 1976. 106 Jelinek JE: The skin in diabetes mellitus: Cutaneous manifestations, complications and associations. In Year Book of Dermatology. Edited by AE Kopf, E. Andriade Chicago , Year Book Medical Publishers, 1970, p 5. 107 Grossman ME, Bickers DR, Poh-Fitzpatrick MB, et al: Porphyria cutanea tarda. Am J Med 67: 277, 1979. 108 Topi G, D'Allesandro L: Inheritance of porphyria cutanea tarda. Br J Dermatol 97: 617, 1977. 109 Burnham TK, Fosnaugh RP: Porphyria, diabetes and their relationship. Arch Dermatol 83: 717, 1961. 110 Benedetto AV, Kushner JP, Taylor JS: Porphyria cutanea tarda in three generations of a single family, N Engl J Med 298: 358, 1978. 111 Robert Von P, Zurcher H: Pigmentsudien. Dermatologica 100: 217, 1950. 112 Buckley WR: Localized argyria. Arch Dermatol 88: 531, 1963. 113 Perdrup A, Poulsen H: Hemochromatosis and vitiligo. Arch Dermatol 90: 34, 1964. 114 Cartwright GE, Edwards CQ, Kravitz K, et al: Hereditary hemochromatosis: Phenotypic expression of the disease. N Engl J Med 301: 175, 1979. 115 Edwards CQ, Cartwright GE, Skolnick MH, et al: Homozygosity for hemochromatosis: Clinical manifestations. Ann Intern Med 93: 519, 1980. 116 Beaumont C, Simon M, Fauchet R, et al: Serum ferritin as a possible marker of hemochromatosis allele. N Engl J Med 301: 169, 1979. 117 Milder MS, Cook JD, Stray S, et al: Idiopathic hemochromatosis, an interim report. Medicine 59: 34, 1980. 118 Dymock IW, Cassar J, Pyke DA, et al: Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of hemochromatosis. Am J Med 52: 203, 1972. 119 Saddi R, Feingold J: Idiopathic haemochromatosis and diabetes mellitus. Clin Genet 5: 242, 1974. 120 Buschke A: Vorstellung einesfalles von Sklerodem (vor der Berliner Gesellsch Dermatologic). Arch Dermatol Syphilol 53: 383, 1900. 121 Fleischmajer R, Faludi G, Krol S: Scleredema and diabetes mellitus. Arch Dermatol 101: 21, 1970. 122 Cohn BA, Wheeler CE, Griggaman RA: Sclerdema adultorum of Bushke and diabetes mellitus. Arch Dermatol 101: 27, 1970. 123 Cattell A, Waddinton E: Scleredema and diabetes mellitus. Br J Dermatol 89 (Suppl): 9, 1973. 124 Krall LP, Zorilla E: Disorders of skin and diabetes. In: Joslin's Diabetes Mellitus. A Marble, P White, et al., ed. Philadelphia , Lea & Febiger, 1971, pp 653–665. 125 Heuston JT, Hurley JV, Whittingham S: The contracting fibroblast as a clue to Dupuytren's Contracture. Hand 8: 10, 1976. 126 Lieberman LS, Rosenbloom AL, Riley W, et al: Reduced skin thickness with pump administration of insulin (letter). N Engl J Med 303: 940, 1980. 127 Becker SW, Kahn D, Rothman S: Cutaneous manifestations of internal malignant tumours. Arch Dermatol Syphilol 45: 1069, 1942. 128 Sweet RD: A dermatosis specifically associated with a tumour of pancreatic alpha cells. Br J Dermatol 90: 301, 1974. 129 Kahan RS, Perez-Figaredo RA, Neimanis A: Necrolytic migratory erythema: Distinctive dermatosis of glucagonoma syndrome. Arch dermatol 113: 792, 1977. 130 Swenson KH, Amon RB, Hanifin JM: The glucagonoma syndrome. Arch Dermatol 114: 224, 1978. 131 Goodengerber DM, Lawley TJ, Strober W, et al: Necrolytic migratory erythema without glucagonoma: Report of 2 cases. Arch Dermatol 115: 1429, 1979. 132 Doyle JA, Schroeder AL, Rogers RS: Hyperglucagonemia and necrolytic migratory erythema in cirrhosis: Possible pseudoglucagonoma syndrome. Br J Dermatol 101: 581, 1979. 133 Mallinson CN, Bloom SR, Warin AP, et al: Glucagnoma syndrome. Arch Dermatol 114: 224, 1978. 134 Lewis AE: The glucagonoma syndrome. Int J Dermatol 18: 17, 1979. 135 Tasman-Jones C, Kay RG: Zinc deficiency and skin lesions. N Engl J Med 293: 830, 1975. 136 Tucker SB, Schroeter AL, Brown PW, et al: Acquired zinc deficiency: Cutaneous manifestations typical of acrodermatitis enteropathica. JAMA 235: 2399, 1976. 137 Nelder KH, Hambridge KM: Zinc therapy of acrodermatitis enteropathica. N Engl J Med 292: 879, 1975. 138 McMillan DE: Deterioration of microcirculation in diabetes. Diabetes 24: 944, 1975. 139 Rocca FP, Pereya E: Phylctenar lesions in the feet of diabetic patients. Diabetes 12: 220, 1963. 140 Cantwell AR, Martz W: Idiopathic bullae in diabetes. Arch Dermatol 96: 42, 1967. 141 Bear CL Wall LM: Idiopathic bullae in diabetics. Austral J Dermatol 10: 33, 1969. 142 Allen GE, Hadden DR: Bullous lesions of the skin in diabetes (Bullosis diabeticorum). Br J Dermatol 82: 216, 1970. 143 Bernstein JE, Medenica M, Soltani K, et al: Bulous eruption of diabetes mellitus. Arch Dermatol 115: 324, 1979. 144 Paltzik RL: Bullous eruption of diabetes mellitus: Bullosis diabeticorum. Arch Dermatol 116: 475, 1980. 145 Gilchrist B. Row JW, Mihm MC: Bullous dermatosis of hemodialysis. Ann Intern Med 83: 480, 1975. 146 Keczkes K, Farr M: Bullous dermatosis of chronic renal failure. Br J Dermatol 95: 541, 1976. 147 Poh-Fitzpatrick MB, Masullo AS, Grossman ME: Porphyria cutanea tarda associated with chronic renal disease and hemodialysis. Arch Dermatol 116: 191, 1980. 148 Lerner AB: Vitiligo. J Invest Dermatol 32: 285, 1959. 149 Lerner AB, Snell RS, Chanco-Turner ML, et al: Vitiligo and sympathectomy. Arch Dermatol 94: 269, 1966. 150 Lerner AB: On the etiology of vitiligo and gray hair. Am J Med 51: 141, 1971. 151 Woolfson H, Finn OA, Mackie RM et al: Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol 92: 395, 1975. 152 Dawber RP, Bleehen SS, Vallane OJ: Vitiligo and diabetes mellitus. Br J Dermatol 84: 600, 1971. 153 Macaron C. Winter RJ, Traisman HS, et al: Vitiligo and juvenile diabetes mellitus. Arch Dermatol 113: 1515, 1977. 154 Retprnaz G, Betvel H, Ortonee JP, et al: HLA antigens and vitiligo. Br J Dermatol 95: 173, 1976. 155 Kachru RB, Telischi M, Mittal KK: HLA antigens and vitiligo in an American black population. Tissue Antigens 12: 396, 1978. 156 Mosher DB, Parrish JA, Fitzpatrick TB: Monobenzylether of hydroquinone: A retrospective study of treatment of 18 vitiligo patients. Br J Dermatol 97: 669, 1977. 157 Parrish JA, Fitzpatick TB, Shea C, et al: Photochemotherapy of vitiligo: Use of orally administered psoralens and a high intensity longwave ultra-violet light system. Arch Dermatol 112: 1531, 1976. 158 Stern RS, Thibodeau LA, Kleinerman RA, et al: Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy of psoriasis. N Engl J Med 300: 809, 1979. 159 Reed RE, Fusaro RM, Fisher L: Psoriasis vulgaris: A clinical survey of the association with diabetes mellitus. Arch Dermatol 89: 205, 1964. 160 Burns RE, Whitehouse FW: Evidence for impaired glucose tolerance in uncomplicated psoriasis. Arch Dermatol 107: 371, 1973. 161 Gibson SH, Perry HO: Diabetes and psoriasis. Arch Dermatol 74: 487, 1956. 162 Brownstein MH: Psoriasis and diabetes mellitus. Arch Dermatol 95: 255, 1967. 163 Lynch PJ: Psoriasis and blood sugar levels. Arch Dermatol 95: 255, 1967. 164 Gomez EC, Frost P: Induction of glycosuria and hyperglycemia by topical corticosteroid therapy. Arch Dermatol 112: 1559, 1976. 165 Uehara M, Fujigaki T, Hayashi S: Glucose tolerance in pustulosis palmaris et plantaris. Arch Dermatol 116: 1276, 1980. 166 Halevy S, Feuerman EJ: Abnormal glucose tolerance associated with lichen planus. Acta Derm Venereol 59: 167, 1979. 167 Carter VH, Constantine VS: Kryle's disease. Arch Dermatol 97: 624, 1978. 168 Poliak SC, Lebwohl MG, Parris A, et al: Reactive perforating collagenosis associated with diabetes mellitus. N Engl J Med 306: 81, 1982. 169 Laor Y, Schwartz RA: Epidemiologic aspects of American Kaposi's Sarcoma. J Surg Oncol 12: 299, 1979. 170 Cudworth AG, Festenstein H: HLA genetic heterogeneity in diabetes mellitus. Br Med Bull 34: 285, 1978. 171 Dahl MV: HLA, la and the skin. In: Yearbook of Dermatology, Edited by RL Dobson, BH. Thiers Chicago , Yearbook Medical Publishers, 1980, p 13. 172 Holt S, Blackwell JN: Dermatitis herpetiformis and diabetes mellitus. Postgrad Med J 56: 15, 1980. 173 Krawisz JE, Palumbo PJ, Taswell HF, et al: HLA antigens in patients with juvenile diabetes and their first-degree relatives. Mayo Clin Proc 53: 782, 1978. 174 Serjeantson S, Kirk RL, Dry PJ, et al: HLA studies in Australian multiple-case families of juvenile onset diabetes mellitus. Med Aust J 1: 107, 1980. Citing Literature Volume23, Issue9October 1984Pages 567-584 ReferencesRelatedInformation
Referência(s)